Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disorder Therapeutics Market: A Key Driver Powering Neurodegenerative Disorder Therapeutics Market Growth In 2025

"The Neurodegenerative Disorder Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Neurodegenerative Disorder Therapeutics Market Size and Its Estimated Growth Rate?
The neurodegenerative disorder therapeutics market has shown strong growth, expected to increase from $18.53 billion in 2024 to $20.04 billion in 2025, with a CAGR of 8.1%. This expansion is attributed to the aging population, the rising prevalence of neurodegenerative diseases, longer life expectancy, increasing pharmaceutical investments, and heightened awareness and advocacy.

The neurodegenerative disorder therapeutics market is set to grow strongly, reaching $28.33 billion in 2029 at a CAGR of 9.0%. Drivers include demand for personalized treatment, access to trials, healthcare spending growth, and targeted therapies. Key trends are disease-modifying drugs, tech-driven interventions, remote monitoring, digital health integration, and biomarker-focused clinical research.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2818

How Are Emerging Segments Shaping the Neurodegenerative Disorder Therapeutics Market Landscape?
The neurodegenerative disorder therapeutics market covered in this report is segmented -

1) By Indication Type: Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types
2) By Drug Type: N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types
3) By Distribution: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Parkinson's Disease: Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics
2) By Alzheimer's Disease: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Anti-Amyloid Monoclonal Antibodies
3) By Multiple Sclerosis: Immunomodulators, Immunosuppressants, Corticosteroids
4) By Huntington's Disease: Tetrabenazine, Antipsychotic Medications
5) By Other Indication Types: Amyotrophic Lateral Sclerosis (ALS) Treatments, Frontotemporal Dementia Treatments, Prion Disease Treatments

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2818&type=smp

Which Growth Factors Are Influencing Neurodegenerative Disorder Therapeutics Market Expansion?
The increasing prevalence of neurodegenerative disorders, especially among the aging population, is contributing to the growth of the neurodegenerative disorder therapeutics market. The number of individuals aged 60+ is projected to grow to 2.1 billion by 2050, with those aged 80+ tripling to 425 million. Alzheimer's disease alone affects 5.8 million Americans, a number expected to rise to 14 million by 2050. The rising incidence of such diseases drives the demand for neurodegenerative disorder treatments.

Who Are the Dominant Players Across Different Neurodegenerative Disorder Therapeutics Market Segments?
Major companies operating in the neurodegenerative disorder therapeutics market include Biogen Inc., Pfizer Inc., Novartis International AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., UCB S.A., F. Hoffmann-La Roche Ltd., ACADIA Pharmaceuticals Inc., H. Lundbeck A/S, Boehringer Ingelheim International GmbH, Merck Serono S.A., Orion Corporation, Mitsubishi Tanabe Pharma America, Allergan PLC, GlaxoSmithKline PLC, AbbVie Inc., Eli Lilly and Company, Celgene Corporation, Neuro-Hitech Inc., Bayer Schering Pharma AG, Amarin Corporation PLC, AstraZeneca plc, Alector Inc., Yumanity Therapeutics Inc., Yangtze River Pharmaceutical Group Co. Ltd., Chongqing Zein Pharmaceutical Co. Ltd., Eisai Co. Ltd., Bristol Myers Squibb Company, AB Science S.A., Amylyx Pharmaceuticals Inc., Genentech Inc., GenSight Biologics S.A., AC Immune SA, Annexon Bioscience Inc., BioArctic Neuroscience AB, Cajal Neuroscience Inc., Cognito Therapeutics Inc., Grifols S.A., New Equilibrium Biosciences Inc., Prothena Corporation PLC, Tessera Therapeutics Inc., Vigil Neuroscience Inc.

What Are the Major Trends Shaping the Neurodegenerative Disorder Therapeutics Market?
Companies in the neurodegenerative disorder therapeutics market are partnering with government and non-government organizations to develop treatments for various neurodegenerative diseases. For example, in July 2022, NRG Therapeutics partnered with Domainex to develop disease-modifying medications for Parkinson's disease and motor neuron disease, advancing the development of therapeutic solutions in the market.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Which Geographic Regions Are Expected to Dominate the Neurodegenerative Disorder Therapeutics Market in the Coming Years?
The countries covered in the neurodegenerative disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Neurodegenerative Disorder Therapeutics Market?
2. What is the CAGR expected in the Neurodegenerative Disorder Therapeutics Market?
3. What Are the Key Innovations Transforming the Neurodegenerative Disorder Therapeutics Industry?
4. Which Region Is Leading the Neurodegenerative Disorder Therapeutics Market?

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.